Global Equity Fund

Share Class Investor  
Ticker CAMGX  
Inception Date 11.30.2011
Minimum Investment       $2,500  

2017 Final Capital Gain Distributions

The Cambiar Global Equity Fund is structured as a ‘best ideas’ portfolio, whereby sourcing of new ideas will come from Cambiar’s existing domestic and international portfolios.  

The Fund has the ability to seek investment opportunities from across the globe, making it Cambiar's most diversified portfolio.  

  • Flexibility to invest in all corners of the world.
  • Equal-weighted approach - All new stock positions enter the portfolio at 2% position sizes. This construction is designed to reduce excessive stock-specific risk, while allowing for the freedom to participate on the upside. 
  • Fund will take a broadly neutral weight relative to the U.S. and international exposure found in the benchmark
  • The Fund attempts to hold between 45-55 stocks.

Portfolio Managers

AniaA(2016) 

Ania A. Aldrich, CFA 

    

ToddE(2016) 

Todd L. Edwards, PhD 

    

AlvaroS(2016)

Alvaro Shiraishi

Morningstar Rating™

Performance Charts

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. Returns assume reinvestment of all dividend and capital gains distributions. Expense ratio is 1.84% (gross); 1.10% (net). Cambiar Investors, LLC has contractually agreed to reduce fees and reimburse expenses in order to keep net operating expenses from exceeding 0.95% of the average daily net assets of each of the Fund’s share classes until September 1, 2018.  Absent these waivers, total return would be reduced. For performance current to the most recent month-end, please call 1-866-777-8227. The MSCIWorld and ACWI Index are an unmanaged index compiled by Morgan Stanley Capital International. The MSCI indices returns do not reflect any management fees, transaction costs or expenses. Individuals cannot invest directly in an index.

The Fund charges a 2.00% redemption fee on redemptions of shares held for less than 90 days. 

Portfolio Profile (as of 12.31.2017)

Top 10 Holdings % Weight
HSBC 2.4
Alphabet 2.4
Royal DSM 2.3
AIA Group 2.3
Twitter 2.2
Citigroup 2.1
Komatsu 2.1
Baidu 2.1
Bristol-Myers Squibb 2.1
Royal Dutch Shell 2.1
% of Total 22.1
Holdings Subject to Change  
Attributes Cambiar MSCI World MSCI ACWI
Price/Earnings F1Y 15.7 16.9 16.2
Price/Book 2.0 2.4 2.3
Debt/Equity  1.4 1.2 1.1
EPS Growth  10.8 12.9 13.5
Market Cap Wtd Avg 84.2 B 135.9 B 131.6 B
Market Cap Median 50.8 B 13.5 B 11.2 B
Active Share 92.4    
Sector Weights   Cambiar      MSCI World MSCI ACWI
Consumer Discretionary 5.9 12.3 12.0
Consumer Staples 12.4 9.0 8.7
Energy 9.6 6.3 6.4
Financials 20.1 18.1 18.7
Health Care 13.5 11.8 10.7
Industrials 13.6 11.6 10.8
Information Tech 14.1 16.8 18.1
Materials 4.5 5.2 5.5
Real Estate 1.8 3.1 3.1
Telecom Services 2.0 2.8 3.0
Utilities 1.9 3.0 2.9
Cash 0.4    
Top 5 Countries     Cambiar MSCI World MSCI ACWI
United States 41.1 58.9 52.0
France 12.0 4.0 3.5
United Kingdom 9.7 6.2 5.5
Netherlands 8.9 1.9 1.7
Japan 8.1 8.9 7.9
Risk Statistics* Cambiar MSCI World MSCI ACWI
Alpha -0.5 0.0 0.0
Beta 1.0 1.0 1.0
R-Squared 86.0 100 98.8
Sharpe Ratio 0.5 0.9 0.9
Standard Deviation 10.5 10.4 10.5
*Three Year      

Commentary

Market Review (12.31.2017)

Global equities extended their year-long upward trajectory into the fourth quarter, closing out 2017 at or near their high water marks for the year.  The positive sentiment towards stocks was primarily in response to an accelerating global economy, which bodes well for corporate profits.  U.S. stocks received a boost from the U.S. tax reform bill, which should be an additional tailwind to earnings and provides corporates with more firepower that can be deployed via share buybacks, increased dividends or strategic merger/acquisition activity.   

Posting a full-year return of 25%, the MSCI EAFE Index bested the S&P 500 Index return of 21.8% - marking the first year since 2012 where international developed stocks outpaced their U.S. counterparts.  Emerging markets was the standout performer in 2017, with the MSCI Emerging Markets Index gaining 37%.  While valuation levels have moved higher regardless of geography, international markets may continue to offer a more attractive risk/reward vs. U.S. stocks, based on one-year forward multiples:

 

Market Index One-Year Forward P/E
S&P 500 18.2x
Nikkei 225 17.5x
FTSE 100  14.7x
DAX 13.4x
CAC 40 14.7x
MSCI Europe 14.9x
MSCI Emerging Markets 12.6x

Source: Factset

Given current valuation levels for U.S. stocks, further upside should primarily be a function of earnings growth, as we believe multiple expansion beyond current levels will be difficult.  In contrast, international markets offer the potential for multiple expansion as well as a continued recovery in earnings.  

Global Equity Fund

The Cambiar Global Equity Fund slightly lagged the strategy’s assigned benchmarks during the quarter.  While the objective is to outperform both of these indices on a rolling three-year basis, we view the MSCI World Index to be the appropriate performance bogey – given Cambiar’s developed market bias.  The portfolio will selectively participate in emerging markets (EM - currently 6%), but has generally not approached the 12% allocation that EM comprises in the MSCI ACWI. 

The Global portfolio generated a strong absolute return for 2017, but was unable to keep pace with the benchmark for the year.  The relative underperformance was sustained in the first two quarters of the year – which was fairly narrow in scope, and exhibited a strong preference for growth over value.  As the rally in equities broadened in the second half of the year, the Cambiar portfolio fared much better.  Looking ahead to 2018, we believe the portfolio remains attractively valued and diversified at the country/region and sector levels. 

The 4Q gain in global equities was broad-based on a sector level, with utilities as the one exception (posted a small loss for the quarter).  The Global portfolio was paced by positive stock selection in the materials, telecom and industrials sectors.  Energy was another bright spot for Cambiar; after a tough start to the year, energy stocks rebounded in the second half on stronger oil prices. 

Representing approximately 20% of the Global Fund, Financials remains the largest sector allocation.   Although Cambiar’s holdings posted an in-line performance for the quarter, the sector was a strong contributor for the portfolio in 2017.  Possessing what we feel to be strong capital positions, Cambiar’s bank, insurance and related financials holdings offer a combination of good earnings growth and high dividend yields.  The potential for rising yields in 2018 will be an additional tailwind for many of the portfolio’s spread income businesses. 

As was the case for much of 2017, tech stocks were the top gainers in the fourth quarter.  The Global portfolio’s lower allocation to this top-performing sector (as well as modestly lower returns) was a detraction from performance – for 4Q as well as on a full year basis.  Bright spots in the portfolio included HP Inc. (the printer segment of the former Hewlett Packard) and Baidu.  One name that did not participate in the year was Qualcomm; the stock was down early in the year due to a royalty dispute with Apple before rallying in 4Q on news that Broadcom was interested in acquiring the company.  Cambiar anticipates a stronger 2018 from Qualcomm; the company is laying the foundation for growth outside of smartphones, while the Broadcom offer helps put a floor under the stock.   

Positive stock selection in basic materials and industrials was offset by below-benchmark returns in consumer discretionary and healthcare.  This dynamic was true for the quarter as well as on a full year basis.  Within discretionary, the traditional retail industry continues to face a challenging competitive environment from e-commerce.  While valuations have compressed in the space, Cambiar continues to maintain a fairly cautious outlook.  The portfolio does own a Japanese retailer that we believe has a defensible brand and market position.  As it relates to healthcare, there were no outsized drawdowns from Cambiar’s holdings in the sector.  Rather, the relative underperformance was simply a case of not keeping pace with the benchmark.  We are optimistic that detractors such as Bristol-Myers and Medtronic can deliver improved results in 2018.

As mentioned, Cambiar’s energy positions were a positive contributor in the quarter, but represented a headwind for the portfolio on a full year basis.  The Global portfolio was overweight energy throughout 2017 – not the correct call in hindsight.  Despite the sector’s soft showing in 2017, Cambiar’s continued constructive view towards energy is a function of improving fundamentals in the industry.  U.S. oil inventories continue to decline from their February peak, and OPEC extended their production limits – all of which is helping to bring greater equilibrium to the global oil markets.  At the company level, managements reaffirm their focus on free cashflow and expense discipline.  The result (hopefully) is greater earnings visibility vs. the rollercoaster ride of recent years.   

The Global Equity Fund held an average cash position of ~4% over the course of the year, creating a drag on return given the strong move in stocks during 2017.  While acknowledging that any cash balance is a negative contributor in a rising market, cash levels are a by-product of the buy/sell process.  As would be expected, cash is a relative non-factor when evaluating performance over longer timeframes.

Looking Ahead

Global equities delivered a dream year for investors – strong returns with very low volatility.  As we contemplate the outlook for equities in 2018, two key considerations are global growth and valuations.  The acceleration in economic growth across most geographies is unlikely to sharply decelerate in 2018, providing a tailwind to corporate profits and stock prices.  That said, it is improbable that 2018 will be without some degree of increased volatility along the way.  Volatility is not necessary a bad thing – the corresponding increase in dispersion across sectors is beneficial to active managers such as Cambiar. 

Regarding valuation, it is hard to argue that equities in the aggregate are inexpensive.  With that said, it is worth noting that the expansion in multiples has not been uniform – by geography nor by sector.  For example, although U.S. stock averages are at all-time highs, market levels in Japan, the United Kingdom and Europe are still below their 2007 levels (in dollar terms).  Such variances provide an additional opportunity for active managers to outperform.

What unforeseen shocks could derail the upward trajectory for equities?  Geopolitical risk is always front of mind; changes in central bank monetary policy will be another variable worth watching.  Although the three rate increases by the Federal Reserve did little to impede stocks from advancing in 2017, the ongoing normalization in policy should eventually be felt by market participants (particularly those with higher leverage ratios).  And while generally accommodative monetary policy continues in Japan, the European Central Bank is likely to articulate their plan to end quantitative easing at some point in 2018.  The mood at Cambiar is best described as constructive paranoia; while optimistic in the outlook for our companies, we spend equal time thinking about what could go wrong.

 

Disclosure

Mutual fund investing involves risk, including the possible loss of principal. In addition to the normal risks associated with investing, investments in smaller companies typically exhibit higher volatility and international investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from economic or political instability in other nations.  Emerging markets involved heightened risks related to the same factors as well as increased volatility and lower trading volume.  There can be no assurance that the Fund will achieve its stated objectives.

To determine if a Fund is an appropriate investment for you, carefully consider the Fund’s investment objectives, risk factors and charges and expenses before investing. This and other information can be found in the Fund’s prospectus which can be obtained by clicking here or calling 1-866-777-8227. Please read it carefully before investing. There is no guarantee that the Funds will meet their stated objectives.

Performance data quotes are past performance and does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. For performance data current to the most recent month-end, please call 1-866-777-8227.

Price/Earnings F1Y is a calculation that divides the current share price by the estimates of earnings in the next four quarters. Debt/Equity - Long Term is a calculation that takes interest bearing, long-term debt divided by shareholder equity. EPS Growth - Long Term is a calculation that takes the company’s estimated profits for five years divided by the outstanding shares. Alpha is a measure of risk-adjusted performance. Beta is a measure of risk in relation to the market or benchmark. The Sharpe Ratio is a direct measure of reward-to-risk and is calculated by subtracting the risk free rate from the rate of return for a portfolio and dividing the result by the standard deviation. Standard Deviation is a statistical measure of historical volatility; a measure of the extent to which numbers are spread around their average. R-Squared measures how closely a portfolio’s performance correlates with the performance of a benchmark index.  These calculations are not a forecast of the Fund’s future performance. 

The Morningstar RatingTM for funds, or "star rating", is calculated for managed products (including mutual funds, variable annuity and variable life subaccounts, exchange-traded funds, closed-end funds, and separate accounts) with at least a three-year history. Exchange-traded funds and open-ended mutual funds are considered a single population for comparative purposes. It is calculated based on a Morningstar Risk-Adjusted Return measure that accounts for variation in a managed product's monthly excess performance, placing more emphasis on downward variations and rewarding consistent performance. The top 10% of products in each product category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars, and the bottom 10% receive 1 star. The Overall Morningstar Rating for a managed product is derived from a weighted average of the performance figures associated with its three-, five-, and 10-year (if applicable) Morningstar Rating metrics. The weights are: 100% three-year rating for 36-59 months of total returns, 60% five-year rating/40% three-year rating for 60-119 months of total returns, and 50% 10-year rating/30% five-year rating/20% three-year rating for 120 or more months of total returns. While the 10-year overall star rating formula seems to give the most weight to the 10-year period, the most recent three-year period actually has the greatest impact because it is included in all three rating periods. CAMGX was rated against 720 World Large Stock funds over a three year period and 589 funds over a five-year period. With respect to these World Large Stock funds CAMGX received a rating of 3 stars for the three year and 3 stars for the five year period, respectively. Past performance is no guarantee of future results.

Price/Earninngs F1Y is a calculation that divides the current share price by the estimates of earnings in the next four quarters. Debt/Equity - Long Term is a calculation that takes interest bearing, long-term debt divided by shareholder equity. EPS Growth - Long Term is a calculation that takes the company’s estimated profits for five years divided by the outstanding shares. Active share is a holdings-based measure of active management representing the percentage of securities in a portfolio that differ from those in the benchmark index. Alpha is a measure of risk-adjusted performance. Beta is a measure of risk in relation to the market or benchmark. The Sharpe Ratio is a direct measure of reward-to-risk and is calculated by subtracting the risk free rate from the rate of return for a portfolio and dividing the result by the standard deviation. Standard Deviation is a statistical measure of historical volatility; a measure of the extent to which numbers are spread around their average. R-Squared measures how closely a portfolio’s performance correlates with the performance of a benchmark index.  These calculations are not a forecast of the Fund’s future performance. 

The MSCI World and ACWI index are an unmanaged index compiled by Morgan Stanley Capital International. The MSCI indices returns do not reflect any management fees, transaction costs or expenses. The MSCI indices returns do not reflect any management fees, transaction costs or expenses. Individuals cannot invest directly in an Index. Individuals cannot invest directly in an Index.  

As of 12.31.17 the Global Equity Fund had a 0.0% in Apple, 2.1% in Baidu, 2.0% in Bristol Myers, 0.0% in Broadcom, 1.9% in HP, 1.9% in Medtronics, and 2.0% in Qualcomm.

This material represents the portfolio manager’s opinion and is an assessment of the market environment at a specific point in time and is not intended to be a forecast of future events, or a guarantee of future results. This information should not be relied upon by the reader as research or investment advice or a specific recommendation of securities.

Cambiar Funds are distributed by SEI Investments Distribution Co., 1 Freedom Valley Dr Oaks, PA 19456, which is not affiliated with the Advisor. Cambiar Funds are available to US investors only. Strategies included within the Institutional Investor offer are not mutual funds and are not affiliated with SEI Investments Distribution Co.